XML 16 R4.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Income - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Jan. 01, 2022
Jan. 02, 2021
Dec. 28, 2019
Consolidated Statements of Income      
Revenues $ 720,860 $ 510,928 $ 473,785
Cost of revenues 295,468 216,083 193,571
Gross profit 425,392 294,845 280,214
Operating expenses:      
Research and development 273,208 235,185 205,690
Selling, general and administrative 185,022 166,748 163,167
Operating expenses 458,230 401,933 368,857
Operating loss (32,838) (107,088) (88,643)
Other income (expense):      
Interest income and other, net 5,696 9,027 12,865
Interest expense (31,033) (34,142) (20,233)
Loss from continuing operations before income taxes (58,175) (132,203) (96,011)
Provision (benefit) for income taxes 13,427 (14,602) 6,984
Equity-method earnings 13,728 2,116 320
Loss from continuing operations (57,874) (115,485) (102,675)
Income from discontinued operations, net of income taxes 2,175,273 128,016 121,940
Net income $ 2,117,399 $ 12,531 $ 19,265
Basic earnings (loss) per share:      
Continuing operations (in dollars per share) $ (1.35) $ (2.64) $ (2.37)
Net income (in dollars per share) 49.44 0.29 0.44
Diluted earnings (loss) per share:      
Continuing operations (in dollars per share) (1.35) (2.64) (2.37)
Net income (in dollars per share) $ 47.78 $ 0.28 $ 0.43
Weighted-average common shares outstanding:      
Basic (in shares) 42,830 43,775 43,346
Diluted (in shares) 44,315 44,372 44,290